Debi wrote an interesting post today onHere’s a quick excerptAn innovative trial has shown pazopanib, a new oral angiogenesis inhibitor, to demonstrate interesting activity in difficult to treat non-small-cell lung cancer. 30 out of 35 patients treated with preoperative pazopanib for a minimum of two weeks saw their tumour size shrink by up to [...]

Posted in Non-Small-Cell, Research, Treatment No Comments »

Debi wrote an interesting post today onHere’s a quick excerptWhile lung cancer in smokers and former smokers is the biggest cancer killer by far, lung cancer in people who have never smoked is — by itself — the sixth biggest cancer killer in the United States.
“Most people are not aware that lung cancer among [...]

Posted in Education, Research No Comments »

Debi wrote an interesting post today onHere’s a quick excerpt Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Read the rest of this great post here

Posted in Research, Treatment No Comments »

Debi wrote an interesting post today onHere’s a quick excerptThe targeted therapy gefitinib should be considered first-line in nonsmoking, chemotherapy-naïve Asian patients with advanced non-small-cell lung cancer (NSCLC), according to the results of the phase 3 study presented here at the 33rd European Society for Medical Oncology Congress (ESMO).
The First Line IRESSA Versus Carboplatin/Paclitaxel [...]

Posted in Non-Small-Cell, Research, Treatment No Comments »

Debi wrote an interesting post today onHere’s a quick excerptThe targeted therapy gefitinib should be considered a first-line therapy for non-smoking Asian patients with adenocarcinoma of the lung, one of the most common types of lung cancer, suggests a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Read [...]

Posted in Research No Comments »

Debi wrote an interesting post today onHere’s a quick excerptSwiss drugmaker Roche said on Monday phase III trial data showed that Avastin combined with gemcitabine-cisplatin chemotherapy improved the time patients lived without lung cancer progressing.
Read the rest of this great post here

Posted in Research, Treatment No Comments »

admin wrote an interesting post today onHere’s a quick excerptAccording to the American Institute of Stress, between 75 and 90 percent of visits to primary care physicians are for stress-related ailments and conditions, such as headaches, back and neck pain, fatigue, insomnia, digestive problems, depression, and chronic pain syndromes.
All of these stress-related conditions can [...]

Posted in Quit Smoking Now No Comments »

Debi wrote an interesting post today onHere’s a quick excerpt Lung cancer remains a major health challenge in the world. Survival for patients with stage I disease ranges between 40-70%.
This suggests that a significant proportion of patients with stage I NSCLC may actually be under-staged.
Methods: In order to identify genes relevant for lung cancer development, [...]

Posted in Research No Comments »

Debi wrote an interesting post today onHere’s a quick excerpt Lung cancer remains a major health challenge in the world. Survival for patients with stage I disease ranges between 40-70%.
This suggests that a significant proportion of patients with stage I NSCLC may actually be under-staged.
Methods: In order to identify genes relevant for lung cancer development, [...]

Posted in Research No Comments »

Debi wrote an interesting post today onHere’s a quick excerptMarshalltown Community School District staff say Bruce Walker has been there for them and now they are taking their turn.
Walker was diagnosed with lung cancer July 10 and his fellow school counselors have got together to sell T-shirts to help pay for Walker’s medical expenses.
“We [...]

Posted in Research, Support No Comments »